| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.34▲ | 1.35▼ | 1.34▲ | 1.39▼ | 1.41▼ |
| MA10 | 1.35▼ | 1.34▲ | 1.36▼ | 1.39▼ | 1.39▼ |
| MA20 | 1.34▲ | 1.37▼ | 1.40▼ | 1.39▼ | 1.41▼ |
| MA50 | 1.38▼ | 1.40▼ | 1.40▼ | 1.40▼ | 2.27▼ |
| MA100 | 1.39▼ | 1.40▼ | 1.40▼ | 1.43▼ | N/A |
| MA200 | 1.39▼ | 1.38▼ | 1.37▼ | 1.88▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.001▼ | -0.009▼ | -0.003▼ | 0.071▲ |
| RSI | 44.131▼ | 38.519▼ | 37.376▼ | 45.351▼ | 40.933▼ |
| STOCH | 23.333 | 46.266 | 13.749▼ | 44.251 | 37.564 |
| WILL %R | -80.000▼ | -64.286 | -82.143▼ | -85.294▼ | -84.686▼ |
| CCI | -20.072 | -29.598 | -70.261 | -153.265▼ | -47.535 |
|
Saturday, December 20, 2025 08:24 PM
No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following oral administration. MIAMI, FL / ACCESS Newswire / December 18, 2025 / ...
|
|
Thursday, November 13, 2025 05:30 AM
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ("Telo" or the "Company"), a leader in diagnostic and prognostic innovation through its ...
|
|
Wednesday, October 22, 2025 03:27 PM
Unifying global IP rights and enabling up to $5 million in potential shareholder contributions, the agreement strengthens Telomir’s foundation for partnerships, licensing, and long-term value creation ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/12/25 | 1.35 | 1.365 | 1.33 | 1.345 | 131,780 |
| 29/12/25 | 1.43 | 1.455 | 1.32 | 1.33 | 609,829 |
| 26/12/25 | 1.42 | 1.46 | 1.39 | 1.46 | 187,743 |
| 24/12/25 | 1.42 | 1.42 | 1.3706 | 1.42 | 193,921 |
| 23/12/25 | 1.39 | 1.44 | 1.39 | 1.40 | 115,002 |
| 22/12/25 | 1.40 | 1.45 | 1.39 | 1.43 | 278,553 |
| 19/12/25 | 1.39 | 1.41 | 1.36 | 1.41 | 283,261 |
| 18/12/25 | 1.38 | 1.42 | 1.35 | 1.37 | 240,693 |
| 17/12/25 | 1.41 | 1.41 | 1.34 | 1.35 | 163,218 |
| 16/12/25 | 1.40 | 1.42 | 1.37 | 1.40 | 163,755 |
|
|
||||
|
|
||||
|
|